MLLT1
Protein ENL
Also known as: ENL, ENL_HUMAN, LTG19, YEATS1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q03111
- Gene
- MLLT1
- Ensembl
- ENSG00000130382
- Chromosome
- 19
- Canonical length
- 559 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center
OverviewNCBI Gene
Predicted to enable chromatin binding activity and lysine-acetylated histone binding activity. Predicted to be involved in positive regulation of DNA-templated transcription. Predicted to act upstream of or within negative regulation of protein kinase activity. Located in cytosol; fibrillar center; and nucleoplasm. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
559 residues, UniProt reviewed canonical sequence.
>Q03111|MLLT1
1 MDNQCTVQVR LELGHRAQLR KKPTTEGFTH DWMVFVRGPE QCDIQHFVEK VVFWLHDSFP
61 KPRRVCKEPP YKVEESGYAG FIMPIEVHFK NKEEPRKVCF TYDLFLNLEG NPPVNHLRCE
121 KLTFNNPTTE FRYKLLRAGG VMVMPEGADT VSRPSPDYPM LPTIPLSAFS DPKKTKPSHG
181 SKDANKESSK TSKPHKVTKE HRERPRKDSE SKSSSKELER EQAKSSKDTS RKLGEGRLPK
241 EEKAPPPKAA FKEPKMALKE TKLESTSPKG GPPPPPPPPP RASSKRPATA DSPKPSAKKQ
301 KKSSSKGSRS APGTSPRTSS SSSFSDKKPA KDKSSTRGEK VKAESEPREA KKALEVEESN
361 SEDEASFKSE SAQSSPSNSS SSSDSSSDSD FEPSQNHSQG PLRSMVEDLQ SEESDEDDSS
421 SGEEAAGKTN PGRDSRLSFS DSESDNSADS SLPSREPPPP QKPPPPNSKV SGRRSPESCS
481 KPEKILKKGT YDKAYTDELV ELHRRLMALR ERNVLQQIVN LIEETGHFNV TNTTFDFDLF
541 SLDETTVRKL QSCLEAVATLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MLLT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 69 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 69 nTPM
- cerebral cortex: 54 nTPM
- basal ganglia: 47 nTPM
- ovary: 45 nTPM
- hippocampal formation: 42 nTPM
- placenta: 40 nTPM
Single-cell type
- syncytiotrophoblasts: 1,341 nCPM
- cytotrophoblasts: 697 nCPM
- migrating cytotrophoblasts: 328 nCPM
- epididymal efferent duct ciliated cells: 134 nCPM
- fallopian tube ciliated cells: 107 nCPM
- neutrophils: 103 nCPM
Immune cell
- neutrophil: 2 nTPM
- plasmacytoid DC: 2 nTPM
- non-classical monocyte: 1.5 nTPM
- intermediate monocyte: 1.2 nTPM
- MAIT T-cell: 0.9 nTPM
- classical monocyte: 0.8 nTPM
Brain region
- cerebral cortex: 90 nTPM
- hippocampal formation: 87 nTPM
- amygdala: 81 nTPM
- cerebellum: 78 nTPM
- basal ganglia: 76 nTPM
- thalamus: 75 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MLLT1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 80 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.29
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 2.69
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MLLT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MLLT1 as an antibody target. Whether an autoantibody or antibody against MLLT1 could matter depends on whether native MLLT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MLLT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MLLT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...